Agilent Technologies and University of Technology, Sydney, Open Joint Nuclear Magnet Resonance Facility
Agilent Technologies Inc. and the University of Technology, Sydney, announced the establishment of a joint nuclear magnetic resonance research facility.
“At UTS, we’re already doing some fantastic work using NMR, including a project looking at the development of more effective fingerprinting techniques by measuring reagent reactions with amino acids,” said professor Philip Doble, UTS School of Chemistry and Forensic Science. “The establishment of this new collaborative facility will provide us with the tools we need to conduct top-quality research into chemistry, biology and forensics.”
The NMR facility will be home to cutting-edge technology to support a range of UTS staff and student research projects, including identifying and measuring drug treatments for osteoporosis, and analyzing solid tissue samples and bacteria in search of more effective treatments for osteoporosis.
This joint NMR facility (a first for Agilent in South Asia Pacific) is part of an ongoing research and technology collaboration between UTS and Agilent. The two organizations established one of the world’s first elemental bio-imaging facilities in 2008.
“Agilent and UTS Science have enjoyed a strong working relationship over the years,” said Rod Minett, general manager, Life Sciences, South Asia Pacific and Korea, Agilent. “Agilent will establish an applications lab at the facility to showcase our current technology. Working in partnership with UTS, our goal is to further enhance the capabilities of NMR to address a range of research challenges in the basic and applied sciences.”
Most read news
Other news from the department science

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.